There have been two very interesting developments in the world of psychotropic pharmacology lately.
The first was a couple months ago, I might have mentioned it, where they are developing a new type of anti-depressant that might be effective in bipolars.
Here is the scoop: there are two types of anti-depressants, MAOIs and SSRIs. MAOIs are very rarely used anymore. They are old and full of nasty side effects, although the efficacy rate was pretty high on that class of drugs. They just aren’t really around, except in special cases. SSRIs (selective serotonin reuptake inhibitors) are the main class of anti-depressants.
The concept is simple: serotonin makes you happy, let’s prevent the serotonin from being absorbed by the brain so it stays out there and keeps you happy. So they designed a drug that inhibits the reuptake of serotonin, get it?